Education
About Us
Working with TipRanks
Follow Us
DaVita (DVA)
NYSE:DVA
DVA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$130.96 - $179.60
Previous CloseN/A
Volume85.32K
Average Volume (3M)909.54K
Market Cap
$10.68B
Enterprise Value$25.65B
Total Cash (Recent Filing)$755.91M
Total Debt (Recent Filing)$3.64B
Price to Earnings (P/E)12.4
Beta0.61
Next Earnings
May 13, 2025EPS Estimate
1.95Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.74
Shares Outstanding80,000,000
10 Day Avg. Volume1,013,548
30 Day Avg. Volume909,543
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)N/A
Price to Sales (P/S)0.92
Price to Cash Flow (P/CF)5.40
P/FCF Ratio6.40
Enterprise Value/Market Cap2.40
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.00
Enterprise Value/Ebitda9.34
Forecast
1Y Price Target
$172.00Price Target Upside27.44% Upside
Rating ConsensusHold
Number of Analyst Covering4
---
DaVita News
PremiumCompany Announcements
DaVita’s Earnings Call: Balancing Growth and Challenges
---
Bulls Say, Bears Say
Bulls Say
Operating Income BenefitInclusion of oral phosphate binders is expected to provide a potential operating income benefit, with the midpoint considered most likely.
Stock Price TargetThe price target for DaVita's stock has been increased to $165, reflecting confidence in future performance.
Bears Say
Cyber IncidentA cyber incident has impacted some company operations and the duration or extent of the disruption is not yet known.
Mortality ImpactDVA expects mortality to remain a headwind to volumes next year.
Weather And Calendar ImpactTreatment growth guidance faces headwinds from severe weather events and the loss of a treatment day due to the leap year effect.
---
Ownership Overview
46.04% Insiders
10.26% Mutual Funds
0.52% Other Institutional Investors
25.85% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DVA FAQ
What was DaVita’s price range in the past 12 months?
DaVita lowest stock price was $130.96 and its highest was $179.60 in the past 12 months.
What is DaVita’s market cap?
DaVita’s market cap is $10.68B.
When is DaVita’s upcoming earnings report date?
DaVita’s upcoming earnings report date is May 13, 2025 which is in 20 days.
How were DaVita’s earnings last quarter?
DaVita released its earnings results on Feb 13, 2025. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.126 by $0.114.
Is DaVita overvalued?
According to Wall Street analysts DaVita’s price is currently Undervalued.
Does DaVita pay dividends?
DaVita does not currently pay dividends.
What is DaVita’s EPS estimate?
DaVita’s EPS estimate is 1.95.
How many shares outstanding does DaVita have?
DaVita has 80,000,000 shares outstanding.
What happened to DaVita’s price movement after its last earnings report?
DaVita reported an EPS of $2.24 in its last earnings report, beating expectations of $2.126. Following the earnings report the stock price went down -11.092%.
Which hedge fund is a major shareholder of DaVita?
Currently, no hedge funds are holding shares in DVA
---
DaVita Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$172.00 (27.44% Upside)
$172.00 (27.44% Upside)
Blogger Sentiment
Bullish
DVA Sentiment 77%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 293.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.44%
12-Months-Change
Fundamentals
Return on Equity
159.08%
Trailing 12-Months
Asset Growth
2.00%
Trailing 12-Months
Company Description
DaVita
DaVita Inc. is a leading healthcare company that primarily focuses on providing kidney care services. Operating within the healthcare sector, DaVita's core services include dialysis treatments for patients with chronic kidney failure and end-stage renal disease. The company operates a network of outpatient dialysis centers across the United States and in various international markets, aiming to enhance the quality of life for its patients through comprehensive care and innovative treatment options.
---
DVA Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
While DaVita Inc. showed strong financial performance and pursued strategic growth initiatives such as the Latin America expansion and transitioning oral drugs, challenges with volume growth, disruptions caused by Hurricane Helene, and international income declines present significant concerns. The sentiment is balanced with achievements in certain areas and setbacks in others.Read More>---
DVA Revenue Breakdown
88.32% U.S. dialysis
11.68% Ancillary services
---
DVA Stock 12 Month Forecast
Average Price Target
$172.00
▲(27.44% Upside)
Technical Analysis
Community Health
―
Fresenius Medical Care
―
HCA Healthcare
―
Tenet Healthcare
―
Universal Health
―
Best Analysts Covering DVA
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+0.80%
assigned a sell rating 6 months ago
Copying Joanna Gajuk's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +0.80% per trade.
---